Effect of Sublingually Generated S-nitroso-N-acetylcysteine on Systemic Blood Pressure.

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
HypertensionCardiovascular Diseases
Interventions
DRUG

Mixture of Sodium Nitrite and N-acetylcysteine (NAC) crytals.

Exactly 2.5 mg or 5 mg sodium nitrite and 50 mg N-acetylcysteine are weighed and mixed together just before use. The mixture is placed under the participant's tongue. The powder slowly dissolves in saliva and generate S-nitrosoacetylcysteine. Investigators will ask the subjects not to swallow the drug at least for 30 min. Administration of nitrite and N-acetylcysteine individually at these concentrations is not expected to change any blood NO chemistry or the systemic blood pressure. Hence, investigators will not investigate the effects of nitrite and N-acetylcysteine individually in this study. Placebo control is not needed for this study because the baseline parameters will serve as control. Investigators will assess the drug effect based on the difference between pre-treatment and post-treatment values.

Trial Locations (1)

35294

RECRUITING

Anesthesiology and Perioperative Medicine, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER